This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

LOR-2040

Aptose Biosciences Inc.

Drug Names(s): GTI-2040

Description: LOR-2040 is an antisense oligonucleotide that is complementary to a region in the R2 small subunit component of human ribonucleotide reductase.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug